Cancer Tests and Diagnosis

  • Cancer
    Cancer is a group of diseases characterised by out-of-control cell growth. There are more than 100 different types of cancer. The cancer is named after the area of the body or organ where it originates.
Submitted by PatientsEngage on 15 October 2015

Early detection can improve the effectiveness and success of the treatment. Depending on the type of cancer, the doctor may recommend some of the following:

  • Imaging techniques such as X-rays, CT scans, MRI scans and ultrasound to locate the tumour and the organ affected by it.
  • Blood samples are analysed for signs of cancer, which may include cancer cells, protein or other substances released by cancer cells. Examples of bloods tests include:
    • Complete blood count: This common blood test is used to measure haemoglobin, red blood cells, white blood cells and platelet count. An abnormal cell count may indicate blood cancer.
    • Tumour Markers: Some tumours release substances called tumour markers, which can be detected in the blood. Examples of tumour markers include prostate-specific antigen (PSA) for prostate cancer, cancer antigen 125 (CA 125) for ovarian cancer, alpha-fetoprotein (AFP) for liver cancer and human chorionic gonadotropin (HCG) for germ cell tumors, such as testicular cancer and ovarian cancer.
    • Blood protein test:This test can detect certain abnormal immune system proteins that are elevated in people with multiple myeloma.
  • Endoscopy to look for abnormalities inside the body
  • Biopsy: Extracting cancer cells and seeing them under a microscope is the only absolute way to diagnose cancer.
Community
Cancer
Condition
Cancer
Changed
Fri, 01/04/2019 - 17:24

Stories

  • Smoking causes lung cancer and...17 other cancers including bladder cancer
    More than half of bladder cancers in the US are the result of smoking, and 90 per cent of smokers with the disease are aware of the connection, according to a new study. "Bladder cancer is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim. Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found…
  • Right-to-die advocate Brittany Maynard ends life
    Brittany Maynard, the terminally ill cancer patient whose viral YouTube video reignited the debate on assisted-suicide, ended her life on Saturday. Bioethicist Arthur L Caplan says that Ms Maynard's story has the potential to change the way many people - particularly younger Americans - view the issue. "I am terrified to think that my children will grow up in a culture that openly venerates suicide with this much unyielding passion” "A whole new generation is now looking at Brittany…
  • Inflammation
    Inflammation has been linked to a slew of diseases – from allergies to cancer, heart trouble, bowel problems and diabetes. What is it and how can we protect ourselves. - By paediatrician and family practitioner Dr Gita Mathai. What is inflammation? The word is derived from the Latin “inflammo” meaning ignite or set alight. It conjures up visions of fire, and it is the body’s response to an injury, like a broken bone, a scrape in the skin or an infection by an organism (…
  • Parents deny girls cancer treatment, say doctors
    Cancer Institute chairperson Dr V Shanta expressed concern over underreporting of cancer among children, especially in rural areas. Advances in oncology over the past six decades have ensured that up to 75 % of all paediatric cancers can be cured. While it is possible to treat all pediatric cases in the country, there is a need to increase affordability and accessibility for the same," she said. http://timesofindia.indiatimes.com/City/Chennai/Parents-deny-girls-cancer-treatment-say-doctors…
  • Chemotherapy explained in Hindi
    Do not fear Chemotherapy ! Understand Chemotherapy and how to deal with it. A great video in Hindi by SanjeevaniLifeBeyondCancer  
  • Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Breast Cancer Patients
    Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
  • My cancer doesn't define who I am
    "I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
  • Joan Lunden talks about her Breast Cancer
    How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
  • Did you know that womb cancer is the fourth most common cancer in women ?
    My cancer could have been caught earlier if I had been alerted about spotting between periods, heavy periods and watery blood between periods as the main symptoms of womb cancer,” she says. But when she asked NHS Choices whether there should be mention of womb cancer on the menopause pages, she received the following reply: “The problem with adding a warning about womb cancer to the menopause pages is that it may cause unnecessary panic.” And this, says Widschwendter, is the nub of the problem…
  • U.S. FDA Approves New Indication for the Use of Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
    The FDA initially approved XTANDI, an oral, once-daily androgen receptor inhibitor, in August 2012 for use in patients with metastatic CRPC who previously received docetaxel (chemotherapy). The new indication approves XTANDI for use in men with metastatic CRPC who have not received chemotherapy. Metastatic CRPC is defined as a cancer that has spread beyond the prostate gland and has progressed despite treatment to lower testosterone (i.e., with a gonadotropin-releasing hormone (GnRH) therapy or…